按容器类型、容器材质、封盖类型、剂型、填充量、最终用户和应用分類的肠外产品包装市场 - 全球预测 2025-2032

预计到 2032 年，肠外产品包装市场将成长 351.1 亿美元，复合年增长率为 10.82%。

主要市场统计数据
基准年2024年	154.3亿美元
预计2025年	171.1亿美元
预测年份：2032年	351.1亿美元
复合年增长率（%）	10.82%

策略介绍，解释为什么肠外包装现在控制着现代治疗产品组合中的产品完整性、法规遵循和供应链弹性

肠外包装处于病人安全、无菌生产和全球供应链复杂性的交汇点，引言解释了为何该领域需要持续的战略关注。随着治疗学向生物製药、组合药物和高灵敏度製剂方向发展，包装已超越了密封功能，成为产品完整性、无菌保证、低温运输相容性和以用户为中心的剂量输送的积极推动者。因此，药物开发、契约製造和分销领域的相关人员必须协调设计控制、监管途径和筹资策略，以保持治疗效果并降低污染风险。

此外，采用这种格局凸显了日益严格的监管、材料创新和客户期望等因素的汇聚，这些因素迫使企业重新思考其传统的包装平台。从说明实践转向规范性实践，需要将需求转化为经过检验的流程，采用先进的二级和三级保障措施，并投资于强大的供应商资格认证计画。这些变化促进了资本配置、营运优先事项、品质、监管和供应链团队之间的跨职能协作。

近期肠外给药包装领域的转型变化反映了从原料采购到最终剂量输送，在技术、监管和商业性驱动因素的推动下，优先事项的快速调整。值得注意的是，材料科学的进步正在加速采用聚合物替代品和工程玻璃配方，以降低分层风险并提高抗破损性。同时，该行业对易于使用的输送系统和紧凑型包装的需求激增，以支援门诊和家庭护理管理，这迫使供应商和开发商重新评估容器形状、封闭介面、密合性测试等。

为了转型到更具弹性的供应网络，製造商越来越多地寻求供应商多元化和区域采购，以减少对先前造成中断的单一来源的依赖。同时，监管部门对人为因素、萃取物和可萃取物以及容器密封完整性测试的重视，提高了包装合格的技术门槛。因此，投资于自动化、封闭式填充系统和严格环境控制的公司正在获得营运优势。这种累积的转变正在推动人们更全面地看待包装，将其视为产品安全、患者体验和商业性差异化的跨学科推动因素。

评估近期美国关税变化如何改变整个肠外包装价值链的采购选择、成本考量与近岸外包策略

美国关税的征收和贸易政策的调整，为依赖全球包装零件采购的组织带来了新的成本、时间和采购考量。为此，采购团队正在重新调整其供应商策略，透过增加在地采购、协商包含保障措施的长期合约以及参与关税分类审查以确保准确的协调制度编码来降低关税风险。采取这些措施有助于减轻意外的关税负担，并简化与海关的互动。

此外，关税促使一些製造商将关键生产过程在地化，或与区域加工商建立策略伙伴关係关係，以保持价格竞争力并缩短前置作业时间。虽然供应链资源配置可以提高应对力，但也需要在新地区投资品质系统和合规能力。因此，监管协调、员工培训和资本投资对于实现近岸外包的营运效益至关重要。最终，关税变化的累积影响需要进行更全面的服务成本分析，以权衡关税对库存、前置作业时间和法规合规性的影响。

详细的细分洞察揭示了容器类型、材料、封盖、剂型、填充量、用户偏好和应用如何推动包装决策和测试需求

对细分市场的细緻理解，可以揭示技术需求、采购优先顺序和临床用例​​的交集，并推动包装决策。相关人员会根据容器类型，评估安瓿瓶、包装袋、药筒、注射器和管瓶配置在剂量准确性、无菌填充线相容性和病患给药需求方面的优缺点。 PET、聚丙烯和 PVC 等替代塑胶在化学相容性、耐灭菌性和阻隔性方面各有优缺点。这些材料的选择必须与监管要求和相容性测试结果相平衡。

捲边盖、掀盖、橡胶塞和螺旋盖各自具有不同的完整性和无菌处理要求，这反过来又影响特定配方和填充线的封盖选择。液体和冻干粉配方需要不同的封装和重建策略，进一步以剂型对包装方法进行分级。同时，冻干粉有可重构和无菌两种类型，每种都有自己独特的容器封盖完整性标准和重构适用性。填充体积类别——从最多 1 毫升、1-5 毫升、5-10 毫升和 10 毫升及以上——影响填充精度、管瓶几何形状和二次包装尺寸。最后，最终使用者环境（包括门诊、诊所、居家医疗、医院和专科诊所）影响有关易用性、剂量安全特性和便携性的决策。糖尿病、肿瘤学和疫苗等特定应用需求会产生额外的技术和监管要求，最终指南整合包装系统的选择和检验。

从区域比较观点来看美洲、中东和非洲以及亚太地区的供应链结构、法律规范和创新重点有何不同

区域动态对肠外包装的供应链配置、监管协调和创新重点有着强大的影响。在美洲，製造商和加工商通常优先考虑上市速度、生产能力规模以及与当地政府的监管亲和性，同时寻求区域伙伴关係关係以缩短供应线。该地区成熟的製药丛集，加上先进的物流基础设施，强调高效的分销和严格的品质系统。

在欧洲、中东和非洲，复杂的监管环境和跨境贸易规则正在推动检测通讯协定的协调，并在包装决策中更加强调永续性和循环性。该地区的供应商正越来越多地透过开发可回收或减少材料的解决方案来应对强调环境影响的法规。同时，在亚太市场，快速的产能扩张、具有成本竞争力的製造流程以及生物製药的加速应用正在推动对扩充性无菌填充、契约製造和大批量竞争性生产的需求。在整个地区，供应商多元化、区域资格认证计画和品管系统协调等过渡性主题凸显了跨国公司需要采用适合当地法规环境的灵活采购和合规策略。

主要企业竞争考察：供应商和製造商如何透过技术投资、综合服务和弹性伙伴关係模式打造竞争优势

肠外包装生态系统中的领导者正透过在品质、自动化和材料科学方面进行有针对性的投资，从而脱颖而出，同时建立策略合作关係以弥补能力差距。注重封闭系统填充和封盖完整性测试的供应商正在满足客户日益增长的无菌保证期望。同时，开发出可减少分层和萃取物的聚合物配方和表面处理技术的公司正在高价值生物製药应用领域获得技术领先地位。

伙伴关係模式也在不断发展，契约製造和零件供应商提供设计协助、监管文件支援和稳定性测试等综合服务，以加快开发进度。同时，采购团队更加重视供应商的透明度、可追溯性和双重采购，以维持供应的连续性。总而言之，这些倡议表明，该行业正在走向一个协作的价值链，其中技术力、监管应对力和营运韧性决定了竞争优势。

为行业领导者提供切实可行的建议，以提高整个肠外包装整体的供应商合格、技术检验、扩充性和永续性

产业领导者可以采取果断行动，将跨职能部门的优先事项整合到协调一致的蓝图中，以平衡创新与合规，从而确保其包装策略面向未来。首先，组织应优先考虑端到端供应商资格认证，包括可审核文件、材料检验通讯协定和紧急采购计画。其次，投资于增强萃取物和可萃取物、容器密封完整性和人为因素的资格确认测试，将降低产品上市风险并支持监管申报。随着疗法从临床阶段走向商业化供应，此类技术投资将带来回报。

此外，企业应追求可製造性设计，以缩短灌装和封口检验週期，并采用模组化自动化技术高效扩大生产规模。企业还必须考虑永续发展途径，例如采用更轻质的材料、可回收零件和节能工艺，以满足相关人员的期望和监管趋势。最后，领导者应与能够提供协作开发能力和灵活地理​​覆盖范围的加工商和契约製造建立策略伙伴关係。这种方法能够快速回应政策变化、关税和需求波动，同时永续性和品质。

透明的调查方法，描述综合定性、技术文献和最佳实践调查方法，构成报告结论和建议的基础

这项综合研究采用多方法论，整合了初步质性研究、实验室方案审查和二手技术文献，以获得切实可行的见解。初步研究包括与品质保证、监管和采购专业人员进行结构化访谈和研讨会，以揭示营运挑战、供应商选择标准和商业化限制。这些第一手观点与技术白皮书、监管指南文件以及专家同行评审的关于材料相容性、容器密封完整性和包装相关失效模式的研究进行了交叉引用，以确保技术准确性。

为了补充相关人员访谈，我们系统性地回顾了产业最佳实践和案例研究，以获得关于供应商多元化、自动化采用和测试策略的建议。在整个分析过程中，我们透过记录资讯来源纳入标准、将可复製的评估框架应用于定性输入，以及根据既定的监管预期对结论进行交叉检验，保持了方法论的严谨性。因此，我们的调查方法不仅支持稳健且可验证的洞察，还能在必要时适应客户特定的咨询和更深入的定量研究。

结论摘要了策略包装决策如何决定现代疗法的产品安全性、法规遵循和供应链稳健性

总而言之，肠外包装正从以组件为中心的功能转变为影响产品可行性、合规性和供应连续性的战略领域。材料创新、监管部门对安全性和相容性的重视以及不断变化的用户需求正在重新定义整个产品生命週期的包装要求。积极协调技术检验、供应商策略和业务投资的组织将能够降低风险，并在日益复杂的环境中脱颖而出。

展望未来，最具韧性的相关人员将是那些采用跨部门管治、优先考虑供应商透明度并在监管审查前投资自动化和测试能力的利害关係人。透过整合提出的建议和见解，决策者可以应对贸易政策变化、地区差异以及先进疗法的技术需求，确保他们的包装决策既科学合理，又具有营运永续。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 增加使用内建安全装置的预填充式注射器，以显着减少针刺伤害。
• 为了支持永续性努力，一次性管瓶和注射器中越来越多地使用可生物降解的聚合物材料。
• 增强RFID和物联网感测器在肠外包装的应用，实现持续低温运输监控
• 吹灌封技术的进步，结合嵌套托盘形式，最大限度地降低了微生物附着量和污染风险。
• 扩展的双腔注射器系统可实现按需药物重构，提高居家照护环境中患者的便利性
• 创新的阻隔涂层应用于玻璃和聚合物容器，以优化与敏感生物製药的兼容性
• 过渡到整合抗菌过滤技术的多剂量肠外给药容器可延长产品保质期
• 开发儿童安全且适合老年人的封闭系统，提升自行注射的安全性和易用性
• 实施符合全球法规合规性要求的序列化和追踪包装解决方案

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 肠外产品包装市场（依容器类型）

• 安瓿
• 包包
• 墨水匣
• 注射器
• 管瓶

9. 肠外产品包装市场（按容器材质）

• 玻璃
• 塑胶
  • PET
  • 聚丙烯
  • PVC

第 10 章。 肠外产品包装市场按类型划分

• 钳口盖
• 翻盖
• 橡胶塞
• 螺旋盖

第11章 肠外产品包装市场（按剂型）

• 液体
  • 多剂量
  • 单一剂量
• 冻干粉
  • 可复溶粉末
  • 无菌粉剂

12. 肠外产品包装市场（以填充量）

• 1至5毫升
• 5–10毫升
• 10毫升或更多
• 最多 1 毫升

第 13 章。 肠外产品包装市场（依最终用户划分）

• 门诊治疗
• 诊所
• 居家护理
• 医院
• 专科诊所

第 14 章。 按应用分類的肠外产品包装市场

• 糖尿病
• 肿瘤学
• 疫苗

15. 肠外产品包装市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第 16 章。按类别分類的肠外产品包装市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

17. 各国肠外产品包装市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Schott AG
  • Becton, Dickinson and Company
  • Stevanato Group SpA
  • Corning Incorporated
  • Nipro Corporation
  • SGD Pharma SA
  • Tofflon Science and Technology Co., Ltd.
  • Shanghai Pharmaceutical Glass Co., Ltd.

The Parenteral Products Packaging Market is projected to grow by USD 35.11 billion at a CAGR of 10.82% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 15.43 billion
Estimated Year [2025]	USD 17.11 billion
Forecast Year [2032]	USD 35.11 billion
CAGR (%)	10.82%

A strategic introduction that frames why parenteral product packaging now governs product integrity, regulatory compliance, and supply chain resilience across modern therapeutic portfolios

The packaging of parenteral products sits at the intersection of patient safety, sterile manufacturing, and global supply chain complexity, and the introduction frames why this domain demands continuous strategic attention. As therapies evolve toward biologics, combination products, and sensitive formulations, packaging has moved beyond containment to become an active enabler of product integrity, sterility assurance, cold chain compatibility, and user-centric dose delivery. Consequently, stakeholders across pharmaceutical development, contract manufacturing, and distribution must align design controls, regulatory pathways, and procurement strategies to preserve therapeutic performance and mitigate contamination risk.

Furthermore, an introduction to this landscape highlights the converging forces of regulatory tightening, material innovation, and customer expectations that compel organizations to revisit legacy packaging platforms. Transitioning from descriptive to prescriptive practice involves translating requirements into validated processes, adopting advanced secondary and tertiary protection measures, and investing in robust supplier qualification programs. In turn, these changes shape capital allocation, operational priorities, and cross-functional collaboration across quality, regulatory, and supply chain teams.

Recent transformative shifts within parenteral packaging reflect a rapid realignment of priorities that extend from raw material sourcing to final dose delivery, catalyzed by technological, regulatory, and commercial drivers. Notably, material science advances have accelerated adoption of polymeric alternatives and engineered glass formulations that reduce delamination risk and improve breakage resistance. At the same time, the industry is experiencing a surge in demand for user-friendly delivery systems and compact formats that support ambulatory and home care administration, prompting suppliers and developers to re-evaluate container geometries, closure interfaces, and compatibility testing.

Transitioning toward more resilient supply networks, manufacturers increasingly pursue supplier diversification and regional sourcing, reducing single-source dependencies that previously contributed to disruption. In parallel, regulatory agencies are emphasizing human factors, extractables and leachables, and container closure integrity testing, which together raise the technical bar for packaging qualification. Consequently, companies investing in automation, closed-system filling, and stringent environmental controls are gaining operational advantages. These cumulative shifts are driving a more integrated view of packaging as a cross-disciplinary enabler of product safety, patient experience, and commercial differentiation.

Assessment of how recent United States tariff dynamics are altering sourcing choices, cost considerations, and nearshoring strategies across the parenteral packaging value chain

The imposition of tariffs and trade policy adjustments originating from the United States has introduced a new layer of cost, timing, and sourcing considerations for organizations that depend on globally sourced packaging components. In response, procurement teams are recalibrating supplier strategies to mitigate tariff exposure by increasing local sourcing, negotiating longer-term contracts with protective terms, and engaging in tariff classification reviews to ensure accurate harmonized system coding. These measures, taken together, help reduce unexpected duty liabilities and enable smoother customs interactions.

Moreover, tariffs have encouraged some manufacturers to localize critical production steps or enter strategic partnerships with regional converters to preserve price competitiveness and reduce lead times. While supply chain reshoring can enhance responsiveness, it also necessitates investment in quality systems and compliance capabilities in new geographies. Consequently, regulatory alignment, workforce training, and capital investment are essential to realize the operational benefits of nearshoring. Ultimately, the cumulative impact of tariff dynamics compels a more holistic cost-to-serve analysis that weighs duty exposure against inventory, lead time, and regulatory conformity.

Detailed segmentation insights revealing how container types, materials, closures, dosage forms, fill volumes, user settings, and applications collectively dictate packaging decisions and testing needs

A nuanced understanding of segmentation reveals where technical requirements, procurement priorities, and clinical use cases intersect to drive packaging decisions. Based on container type, stakeholders evaluate tradeoffs among ampoule, bag, cartridge, syringe, and vial configurations with respect to dosing accuracy, aseptic fill line compatibility, and patient administration needs. In tandem, container material distinctions between glass and plastic require careful consideration; plastic alternatives such as PET, polypropylene, and PVC present diverse benefits and challenges in chemical compatibility, sterilization tolerance, and barrier properties. These material selections must be balanced against regulatory expectations and compatibility testing outcomes.

Closures also play a pivotal role; crimp caps, flip-off caps, rubber stoppers, and screw caps each introduce distinct integrity profiles and aseptic handling requirements, which in turn affect closure selection for specific formulations and fill lines. The dosage form further stratifies packaging approaches as liquid preparations and lyophilized powder demand different containment and reconstitution strategies. Liquid presentations may be designed for multi-dose or single-dose use, while lyophilized powders appear as reconstitutable powder or sterile powder, each imposing unique container closure integrity criteria and reconstitution compatibility. Fill volume categories ranging from up to 1 milliliter through 1 to 5 milliliters, 5 to 10 milliliters, and above 10 milliliters influence fill accuracy, vial geometry, and secondary packaging dimensions. Finally, the end user environment-spanning ambulatory care, clinic, home care, hospital, and specialty clinics-shapes decisions around ease of use, dosing safety features, and portability. Application-specific demands for diabetes, oncology, and vaccines create additional layers of technical and regulatory requirements, which ultimately guide the selection and validation of integrated packaging systems.

Comparative regional perspectives on how supply chain structure, regulatory frameworks, and innovation priorities differ across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert powerful influence on supply chain configuration, regulatory alignment, and innovation priorities across parenteral packaging. In the Americas, manufacturers and converters often prioritize speed to market, scale manufacturing capability, and regulatory familiarity with local agencies, while also exploring regional partnerships to shorten supply lines. This region's combination of established pharmaceutical clusters and advanced logistics infrastructure supports a focus on efficient distribution and rigorous quality systems.

In Europe, the Middle East & Africa, regulatory complexity and cross-border trade rules encourage harmonized testing protocols and a strong emphasis on sustainability and circularity in packaging decisions. Suppliers in this region increasingly respond to regulatory emphasis on environmental impact by developing recyclable or reduced-material solutions. Meanwhile, in the Asia-Pacific market, rapid capacity expansion, cost-competitive manufacturing, and accelerating adoption of biologics drive demand for scalable sterile filling, contract manufacturing, and high-volume component production. Across regions, transitional themes such as supplier diversification, regional qualification programs, and alignment of quality management systems underscore the need for multinational organizations to adopt flexible sourcing and compliance strategies that are appropriate for local regulatory environments.

Key company-level insights into how suppliers and manufacturers are building competitive advantage through technical investment, integrated services, and resilient partnership models

Leading organizations across the parenteral packaging ecosystem are differentiating through targeted investments in quality, automation, and materials science while forging strategic collaborations to address capability gaps. Suppliers that emphasize closed-system filling and container closure integrity testing are meeting heightened customer expectations for sterility assurance. Concurrently, companies that develop polymer formulations or surface treatments to mitigate delamination and extractables are gaining technical leadership in high-value biologic applications.

Partnership models are evolving; contract manufacturers and component suppliers increasingly offer integrated services that bundle design support, regulatory documentation assistance, and stability testing to shorten development timelines. At the same time, procurement teams are placing greater emphasis on supplier transparency, track-and-trace capabilities, and dual-sourcing arrangements to preserve continuity of supply. Collectively, these behaviors indicate an industry moving toward collaborative value chains where technical competence, regulatory readiness, and operational resilience determine competitive advantage.

Actionable recommendations for industry leaders to strengthen supplier qualification, technical validation, scalability, and sustainability across parenteral packaging operations

Industry leaders can take decisive actions to future-proof packaging strategies by integrating cross-functional priorities into a coherent roadmap that balances innovation with compliance. First, organizations should prioritize end-to-end supplier qualification that includes audit-ready documentation, material verification protocols, and contingency sourcing plans; aligning quality, procurement, and regulatory teams reduces the risk of supply interruptions and expedites corrective actions. Second, investment in enhanced compatibility testing for extractables and leachables, container closure integrity, and human factors will de-risk product launches and support regulatory submissions. These technical investments pay dividends when therapies move from clinical stages to commercial supply.

In addition, companies should pursue design-for-manufacturability practices that shorten fill-finish validation cycles and adopt modular automation to scale production efficiently. Firms must also consider sustainability pathways, such as material-lightening, recyclable components, and energy-efficient processes, to meet stakeholder expectations and regulatory trends. Finally, leaders should cultivate strategic partnerships with converters and contract manufacturers that offer co-development capabilities and flexible regional footprints; this approach enables faster response to policy shifts, tariffs, or demand variability while preserving compliance and quality.

Transparent research methodology explaining the integrated qualitative, technical literature, and best-practice review process that underpins the report's conclusions and recommendations

This research synthesis is grounded in a multi-method approach that integrates primary qualitative inquiry, laboratory protocol review, and secondary technical literature to produce actionable insights. Primary engagement included structured interviews and workshops with quality assurance, regulatory, and procurement professionals to surface operational challenges, supplier selection criteria, and commercialization constraints. These firsthand perspectives were triangulated with technical whitepapers, regulatory guidance documents, and peer-reviewed studies on materials compatibility, container closure integrity, and packaging-related failure modes to ensure technical accuracy.

Complementing stakeholder interviews, a systematic review of industry best practices and case studies informed recommendations around supplier diversification, automation adoption, and testing strategies. Throughout the analysis, methodological rigor was maintained by documenting inclusion criteria for sources, applying reproducible evaluation frameworks to qualitative inputs, and cross-validating conclusions against established regulatory expectations. As a result, the methodology supports robust, defensible insights while remaining adaptable to client-specific inquiries and deeper quantitative investigation when required.

Concluding synthesis that encapsulates how strategic packaging decisions now determine product safety, regulatory readiness, and supply chain robustness across modern therapies

In conclusion, parenteral product packaging is transitioning from a component-centric function to a strategic domain that shapes product viability, regulatory success, and supply continuity. Material innovation, regulatory emphasis on safety and compatibility, and evolving user needs are collectively redefining packaging requirements across the product lifecycle. Organizations that proactively align technical validation, supplier strategy, and operational investments position themselves to mitigate risk and unlock competitive differentiation in an increasingly complex environment.

Looking ahead, the most resilient stakeholders will be those that adopt cross-disciplinary governance, prioritize supplier transparency, and invest in automation and testing capabilities that anticipate regulatory scrutiny. By integrating the recommendations and insights presented, decision-makers can better navigate trade policy shifts, regional variations, and the technical demands of advanced therapies, ensuring packaging decisions are both scientifically sound and operationally sustainable.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Increasing adoption of prefilled syringes with integrated safety devices to significantly reduce needlestick injuries
• 5.2. Growing utilization of biodegradable polymer materials in single-use vials and syringes to support sustainability initiatives
• 5.3. Enhanced implementation of RFID and IoT-enabled sensors in parenteral packaging for continuous cold chain monitoring
• 5.4. Advancement of blow-fill-seal technology combined with nested tray formats to minimize bioburden and contamination risk
• 5.5. Expansion of dual-chamber syringe systems enabling on-demand drug reconstitution and improved patient convenience in home care
• 5.6. Innovative barrier coatings applied to glass and polymer containers to optimize compatibility with sensitive biologic formulations
• 5.7. Shift toward multi-dose parenteral containers with integrated antimicrobial filter technology to extend product shelf life
• 5.8. Development of child-resistant, senior-friendly closure systems to enhance safety and usability in self-administered injectables
• 5.9. Implementation of serialization and track-and-trace packaging solutions to meet global regulatory compliance requirements
• 5.10. Introduction of interactive QR code-enabled labels for parenteral products to improve patient engagement and dosing adherence

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Parenteral Products Packaging Market, by Container Type

• 8.1. Ampoule
• 8.2. Bag
• 8.3. Cartridge
• 8.4. Syringe
• 8.5. Vial

9. Parenteral Products Packaging Market, by Container Material

• 9.1. Glass
• 9.2. Plastic
  • 9.2.1. Pet
  • 9.2.2. Polypropylene
  • 9.2.3. Pvc

10. Parenteral Products Packaging Market, by Closure Type

• 10.1. Crimp Cap
• 10.2. Flip Off Cap
• 10.3. Rubber Stopper
• 10.4. Screw Cap

11. Parenteral Products Packaging Market, by Dosage Form

• 11.1. Liquid
  • 11.1.1. Multi Dose
  • 11.1.2. Single Dose
• 11.2. Lyophilized Powder
  • 11.2.1. Reconstitutable Powder
  • 11.2.2. Sterile Powder

12. Parenteral Products Packaging Market, by Fill Volume

• 12.1. 1 To 5 Milliliters
• 12.2. 5 To 10 Milliliters
• 12.3. Above 10 Milliliters
• 12.4. Up To 1 Milliliter

13. Parenteral Products Packaging Market, by End User

• 13.1. Ambulatory Care
• 13.2. Clinic
• 13.3. Home Care
• 13.4. Hospital
• 13.5. Specialty Clinics

14. Parenteral Products Packaging Market, by Application

• 14.1. Diabetes
• 14.2. Oncology
• 14.3. Vaccines

15. Parenteral Products Packaging Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Parenteral Products Packaging Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Parenteral Products Packaging Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. West Pharmaceutical Services, Inc.
  • 18.3.2. Gerresheimer AG
  • 18.3.3. Schott AG
  • 18.3.4. Becton, Dickinson and Company
  • 18.3.5. Stevanato Group S.p.A.
  • 18.3.6. Corning Incorporated
  • 18.3.7. Nipro Corporation
  • 18.3.8. SGD Pharma SA
  • 18.3.9. Tofflon Science and Technology Co., Ltd.
  • 18.3.10. Shanghai Pharmaceutical Glass Co., Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. PARENTERAL PRODUCTS PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. PARENTERAL PRODUCTS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PARENTERAL PRODUCTS PACKAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 219. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 220. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 221. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
• TABLE 222. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
• TABLE 223. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2024 (USD MILLION)
• TABLE 224. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025-2032 (USD MILLION)
• TABLE 225. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 226. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 227. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
• TABLE 228. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
• TABLE 229. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
• TABLE 230. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
• TABLE 231. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
• TABLE 232. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
• TABLE 233. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
• TABLE 234. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2032 (USD MILLION)
• TABLE 235. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2024 (USD MILLION)
• TABLE 236. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2025-2032 (USD MILLION)
• TABLE 237. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 238. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 239. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 240. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 241. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 242. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 243. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
• TABLE 244. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
• TABLE 245. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2024 (USD MILLION)
• TABLE 246. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025-2032 (USD MILLION)
• TABLE 247. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 248. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 249. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
• TABLE 250. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
• TABLE 251. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
• TABLE 252. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
• TABLE 253. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
• TABLE 254. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
• TABLE 255. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
• TABLE 256. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2032 (USD MILLION)
• TABLE 257. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2024 (USD MILLION)
• TABLE 258. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2025-2032 (USD MILLION)
• TABLE 259. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 261. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 262. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 263. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
• TABLE 266. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
• TABLE 267. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2024 (USD MILLION)
• TABLE 268. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025-2032 (USD MILLION)
• TABLE 269. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 270. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 271. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
• TABLE 273. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
• TABLE 274. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
• TABLE 275. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
• TABLE 276. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
• TABLE 277. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
• TABLE 278. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2032 (USD MILLION)
• TABLE 279. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2024 (USD MILLION)
• TABLE 280. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2025-2032 (USD MILLION)
• TABLE 281. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 282. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 283. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 284. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2024 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025-2032 (USD MILLION)
• TABLE 291. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
• TABLE 292. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
• TABLE 295. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
• TABLE 296. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
• TABLE 297. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
• TABLE 298. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
• TABLE 299. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
• TABLE 300. EUROPE, MIDDLE EAST &